Insider · CIK 0001187308
Robert R Ruffolo
director
Files at ELTX (Elicio Therapeutics, Inc.), LBRX (LB PHARMACEUTICALS INC). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | ELTX Elicio Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +21,750 | $0.00 | $0 | 21,750 | 40 d ago |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | DDisposition to issuer Stock Option (Right to Buy)derivative | -1,792 | - | - | 0 | Sep 12, 2025 |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +1,792 | - | - | 1,792 | Sep 12, 2025 |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | DDisposition to issuer Stock Option (Right to Buy)derivative | -717 | - | - | 0 | Sep 12, 2025 |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +717 | - | - | 717 | Sep 12, 2025 |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | DDisposition to issuer Stock Option (Right to Buy)derivative | -10,757 | - | - | 0 | Sep 12, 2025 |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +10,757 | - | - | 10,757 | Sep 12, 2025 |
| Sep 10, 2025 | LBRX LB PHARMACEUTICALS INC | AGrant or award Stock Option (Right to Buy)derivative | +22,449 | $0.00 | $0 | 22,449 | Sep 12, 2025 |
| May 19, 2025 | ELTX Elicio Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +7,900 | $0.00 | $0 | 7,900 | May 20, 2025 |
| Nov 21, 2024 | ELTX Elicio Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +4,100 | $0.00 | $0 | 4,100 | Nov 25, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.